Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 4
2014 8
2015 10
2016 13
2017 4
2018 6
2019 4
2020 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Jackson LR 2nd, Kim S, Blanco R, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Go AS, Kowey PR, Mahaffey KW, Hylek EM, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II. Jackson LR 2nd, et al. Am Heart J. 2020 Aug;226:85-93. doi: 10.1016/j.ahj.2020.04.016. Epub 2020 Apr 28. Am Heart J. 2020. PMID: 32526533
Trends in Treatment for Patients Hospitalized with Heart Failure with Preserved Ejection Fraction Before and After Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT).
Fudim M, Kelly JP, Brophy TJ, DeVore AD, Hammill BG, Peterson ED, Pitt B, Yancy C, Fonarow GC, Hernandez AF. Fudim M, et al. Am J Cardiol. 2020 Jun 1;125(11):1655-1660. doi: 10.1016/j.amjcard.2020.02.038. Epub 2020 Mar 14. Am J Cardiol. 2020. PMID: 32273054
Rhythm Control Versus Rate Control in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction: Insights From Get With The Guidelines-Heart Failure.
Kelly JP, DeVore AD, Wu J, Hammill BG, Sharma A, Cooper LB, Felker GM, Piccini JP, Allen LA, Heidenreich PA, Peterson ED, Yancy CW, Fonarow GC, Hernandez AF. Kelly JP, et al. J Am Heart Assoc. 2019 Dec 17;8(24):e011560. doi: 10.1161/JAHA.118.011560. Epub 2019 Dec 10. J Am Heart Assoc. 2019. PMID: 31818219 Free PMC article.
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation.
Inohara T, Kim S, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators. Inohara T, et al. Heart. 2019 Mar;105(5):370-377. doi: 10.1136/heartjnl-2018-313642. Epub 2018 Sep 18. Heart. 2019. PMID: 30228248
Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry.
Fudim M, Liu PR, Shrader P, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Hylek E, Go AS, Thomas L, Peterson ED, Piccini JP. Fudim M, et al. J Am Heart Assoc. 2018 Apr 13;7(8):e007987. doi: 10.1161/JAHA.117.007987. J Am Heart Assoc. 2018. PMID: 29654203 Free PMC article.
An Observational Study of the Association of Video- Versus Text-Based Informed Consent With Multicenter Trial Enrollment: Lessons From the PALM Study (Patient and Provider Assessment of Lipid Management).
Fanaroff AC, Li S, Webb LE, Miller V, Navar AM, Peterson ED, Wang TY. Fanaroff AC, et al. Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004675. doi: 10.1161/CIRCOUTCOMES.118.004675. Circ Cardiovasc Qual Outcomes. 2018. PMID: 29625993 Free PMC article.
49 results